CNS Pharma

Early Stage

Breakthrough technologies for central nervous system cancers.

Analytics

Raised to Date: Raised: $628,558

Aggregate Commitments $

Platform

Republic

Start Date

03/16/2018

Close Date

06/11/2018

Min. Goal

$100,000

Max. Goal

$1,070,000

Min. Investment

$250

Security Type

SAFE

Funding Type

RegCF

Rolling Commitments $

Status
Funded
Reporting Date

06/30/2018

Days Remaining
Funded
% of Min. Goal

629%

% of Max. Goal

59%

Likelihood of Max
Funded
Avg. Daily Raise

$7,225

# of Investors

666

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

Houston, Texas

Industry

Healthcare & Pharmaceuticals

Tech Sector

Glioblastoma Multiforme (GBM) is one of the deadliest forms of brain cancer -- and CNS Pharma wants to do something about it. They’re in the midst of developing Berubicin, a breakthrough drug whose clinical trials have yielded promising results. Berubicin was created at MD Anderson Cancer Center, and it’s the first of its class of drugs to cross the blood brain barrier and reach cancer cells in brain tumor patients. It’s also been granted Orphan Drug status by the US FDA, and CNS expects to start its Phase 2(a) clinical trial soon. CNS has also entered into a collaboration agreement with Reata Pharmaceuticals and plans to list on the NASDAQ in 2018.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CNS Pharma on Republic
$
Platform: Republic
Security Type: SAFE

Follow company

Follow CNS Pharma on Republic
View on Republic (Closed)
Bullish / Bearish
You're Bullish on CNS Pharma on Republic

Thank you for your vote on CNS Pharma on Republic

Bullish / Bearish
You're Bearish on CNS Pharma on Republic

Thank you for your vote on CNS Pharma on Republic